Search
for
Sort by
Research 421–450 of 1000+
- Update on medical management of benign prostatic hyperplasia
- Court of Appeal can overrule itself to follow the EPO: UK adopts EPO stance on second medical use claims
- Alopecia and its medical management
- The safety and efficacy of finasteride for transgender men with androgenetic alopecia: a case series
- Efficacy and safety of topical finasteride spray solution in the treatment of Chinese men with androgenetic alopecia: A phase III, multicenter, randomized, double-blind, placebo-controlled study
- Michaelis-Menten Kinetic Modification: The Space Pharmaceuticals Bioavailability Approaches Finasteride
- ANDROGENINĖS ALOPECIJOS MEDIKAMENTINIO GYDYMO GALIMYBĖS
- Inhibitory Effects of Pueraria mirifica Aqueous Extracts on 5α-reductase and Prostate Histomorphometry in Testosterone-induced Benign Prostatic Hyperplasia Sprague Dawley Rats
- Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells
- Patient-reported treatment outcomes and safety of direct-to-consumer teledermatology for finasteride treatment in male androgenetic alopecia: A cross-sectional study
- Rapid determination and quantification of hair-growth compounds in adulterated products by ultra HPLC coupled to quadrupole-orbitrap MS
- Konvergentna validacija farmakoekonomskih aspekata terapije benigne hiperplazije prostate u Crnoj Gori
- Hormonal Treatment for Skin Androgen-Related Disorders
- Sex hormones and related compounds, including hormonal contraceptives
- Medical Management Options for Hair Loss
- NEW PROPRIETARY BRANDS: Gabapentin
- NEW PROPRIETARY BRANDS: Cephalexin
- New drugs: Agalsidase beta
- NEW FORMULATIONS: Sodium cromoglycate
- NEW PROPRIETARY BRANDS: Cefaclor monohydrate
- NEW FORMULATIONS: Glatiramer acetate
- Farmácia dos Clérigos - Porto e nos Serviços Farmacêuticos da University College Hospital - Londres, Reino Unido, ao abrigo do programa Erasmus+
- Development and Characterization of Hydrogel containing Finasteride
- Causes of hair loss and the developments in hair rejuvenation
- Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study
- Hair growth promoting effect of white wax and policosanol from white wax on the mouse model of testosterone-induced hair loss
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Serenoa Repens (Saw Palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part III
- Molecular Interactions and Release Mechanisms of Finasteride in β-CD and Trimethyl-β-CD Complexes: A Computational and Experimental Approach
- Persistent Gynecomastia due to Short-term Low-dose Finasteride for Androgenetic Alopecia